Page last updated: 2024-08-25

bendamustine hydrochloride and Hepatitis E

bendamustine hydrochloride has been researched along with Hepatitis E in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alnuaimi, K; Lascoux-Combes, C; Lavolé, J; Mallet, V; Pol, S; Roque Afonso, AM; Sogni, P	1

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Hepatitis E

Article	Year
Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Chronic Disease; Drug Combinations; Fatal Outcome; Female; Hepatitis E; Humans; Lymphoma, Follicular; Rituximab	2018

Article

Year

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine.

Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:6

Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Chronic Disease; Drug Combinations; Fatal Outcome; Female; Hepatitis E; Humans; Lymphoma, Follicular; Rituximab

2018